Anti-CD44 induces apoptosis in T lymphoma via mitochondrial depolarization

Journal of Cellular and Molecular Medicine

Volumn 14, Issue 6 B, 2010, Pages 1453-1467

  Rajasagi, Mohini ^a   von Au, Anja ^a,b   Singh, Rahul ^a   Hartmann, Natalie ^a,c   Zöller, Margot ^a   Marhaba, Rachid ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c Universitätsklinikum für Kinder und Jugendmedizin   (Germany)

Author keywords

Apoptosis; CD44; PP2A; Rodent; Signal transduction

Indexed keywords

CANCER ANTIBODY; CASEIN KINASE II; CASPASE 9; HERMES ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOPROTEIN PHOSPHATASE 2;

ANIMAL; APOPTOSIS; ARTICLE; C57BL MOUSE; CELL PROLIFERATION; DRUG ANTAGONISM; DRUG EFFECT; ENZYME ACTIVATION; ENZYMOLOGY; HEMATOPOIESIS; IMMUNOLOGY; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOMA; METABOLISM; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; MOUSE; PATHOLOGY; PHOSPHORYLATION; SUBCUTANEOUS DRUG ADMINISTRATION; T LYMPHOCYTE; THYMOMA; TUMOR CELL LINE;

ANIMALS; ANTIBODIES, NEOPLASM; ANTIGENS, CD44; APOPTOSIS; CASEIN KINASE II; CASPASE 9; CELL LINE, TUMOR; CELL PROLIFERATION; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HEMATOPOIESIS; INJECTIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; LYMPHOMA; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MICE, INBRED C57BL; MITOCHONDRIA; PHOSPHORYLATION; PROTEIN PHOSPHATASE 2; T-LYMPHOCYTES; THYMOMA; THYMUS NEOPLASMS;

ANIMALIA; MUS; RODENTIA;

EID: 77955133838     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2009.00909.x     Document Type: Article

References (61)

1. Screaton GR, Bell MV, Jackson DG. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA. 1992, 89:12160-4.
2. Lynch KW. Consequences of regulated pre-mRNA splicing in the immune system. Nat Rev Immunol. 2004, 4:931-40.
3. Naor D, Wallach-Dayan SB, Zahalka MA, Sionov RV. Involvement of CD44, a molecule with a thousand faces, in cancer dissemination. Semin Cancer Biol. 2008, 18:260-7.
4. Orian-Rousseau V, Ponta H. Adhesion proteins meet receptors: a common theme. Adv Cancer Res. 2008, 101:63-92.
5. Lapidot T, Dar A, Kollet O. How do stem cells find their way home? Blood. 2005, 106:1901-10.
6. Marhaba R, Klingbeil P, Nübel T. CD44 and EpCAM: cancer-initiating cell markers. Curr Mol Med. 2008, 8:784-804.
7. Lapidot T, Sirard C, Vormoor J. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature. 1994, 367:645-8.
8. Zou GM. Cancer stem cells in leukemia, recent advances. J Cell Physiol. 2007, 213:440-4.
9. Misaghian N, Ligresti G, Steelman LS. Targeting the leukemic stem cell: the holy grail of leukemia therapy. Leukemia. 2009, 23:25-42.
10. Tu LC, Foltz G, Lin E. Targeting stem cells-clinical implications for cancer therapy. Curr Stem Cell Res Ther. 2009, 4:147-53.
11. Miyake K, Medina KL, Hayashi S. Monoclonal antibodies to Pgp-1/CD44 block lympho-hemopoiesis in long-term bone marrow cultures. J Exp Med. 1990, 171:477-88.
12. Khaldoyanidi S, Denzel A, Zöller M. Requirement for CD44 in proliferation and homing of hematopoietic precursor cells. J Leukoc Biol. 1996, 60:579-92.
13. Khaldoyanidi S, Karakhanova S, Sleeman J. CD44 variant-specific antibodies trigger hemopoiesis by selective release of cytokines from bone marrow macrophages. Blood. 2002, 99:3955-61.
14. Ratajczak MZ, Reca R, Wysoczynski M. Heterogeneous populations of bone marrow stem cells - are we spotting on the same cells from the different angles? Folia Histochem Cytobiol. 2004, 42:139-46.
15. Avigdor A, Goichberg P, Shivtiel S. CD44 and hyaluronic acid cooperate with SDF-1 in the trafficking of human CD34+ stem/progenitor cells to bone marrow. Blood. 2004, 103:2981-9.
16. Liu J, Jiang G. CD44 and hematologic malignancies. Cell Mol Immunol. 2006, 3:359-65.
17. Hidalgo A, Robledo MM, Teixidó J. CD44-mediated hematopoietic progenitor cell adhesion and its complex role in myelopoiesis. J Hematother Stem Cell Res. 2002, 11:539-47.
18. Jin L, Hope KJ, Zhai Q. Targeting of CD44 eradicates human acute myeloid leukemic stem cells. Nat Med. 2006, 12:1167-74.
19. Krause DS, Lazarides K, von Andrian UH, Van Etten RA. Requirement for CD44 in homing and engraftment of BCR-ABL-expressing leukemic stem cells. Nat Med. 2006, 12:1175-80.
20. Ponta H, Sherman L, Herrlich PA. CD44: from adhesion molecules to signalling regulators. Nat Rev Mol Cell Biol. 2003, 4:33-45.
21. Marhaba R, Zöller M. CD44 in cancer progression: adhesion, migration and growth regulation. J Mol Histol. 2004, 35:211-31.
22. Hegde VL, Singh NP, Nagarkatti PS. CD44 mobilization in allogeneic dendritic cell-T cell immunological synapse plays a key role in T cell activation. J Leukoc Biol. 2008, 84:134-42.
23. Zhu B, Symonds AL, Martin JE. Early growth response gene 2 (Egr-2) controls the self-tolerance of T cells and prevents the development of lupuslike autoimmune disease. J Exp Med. 2008, 205:2295-307.
24. Nervi B, Link DC, DiPersio JF. Cytokines and hematopoietic stem cell mobilization. J Cell Biochem. 2006, 99:690-705.
25. Föger N, Marhaba R, Zöller M. CD44 supports T cell proliferation and apoptosis by apposition of protein kinases. Eur J Immunol. 2000, 30:2888-99.
26. Marhaba R, Freyschmidt-Paul P, Zöller M. In vivo CD44-CD49d complex formation in autoimmune disease has consequences on T cell activation and apoptosis resistance. Eur J Immunol. 2006, 36:3017-32.
27. Gadhoum Z, Delaunay J, Maquarre E. The effect of anti-CD44 monoclonal antibodies on differentiation and proliferation of human acute myeloid leukemia cells. Leuk Lymphoma. 2004, 45:1501-10.
28. Mielgo A, Brondani V, Landmann L. The CD44 standard/ezrin complex regulates Fas-mediated apoptosis in Jurkat cells. Apoptosis. 2007, 12:2051-61.
29. Nakano K, Saito K, Mine S. Engagement of CD44 up-regulates Fas ligand expression on T cells leading to activation-induced cell death. Apoptosis. 2007, 12:45-54.
30. Ruffell B, Johnson P. Hyaluronan induces cell death in activated T cells through CD44. J Immunol. 2008, 181:7044-54.
31. Hoffmann U, Heilmann K, Hayford C. CD44v7 ligation downregulates the inflammatory immune response in Crohn's disease patients by apoptosis induction in mononuclear cells from the lamina propria. Cell Death Differ. 2007, 14:1542-51.
32. Shi Y, Reiman T, Li W. Targeting aurora kinases as therapy in multiple myeloma. Blood. 2007, 109:3915-21.
33. Zada AA, Singh SM, Reddy VA. Downregulation of c-Jun expression and cell cycle regulatory molecules in acute myeloid leukemia cells upon CD44 ligation. Oncogene. 2003, 22:2296-308.
34. Artus C, Maquarre E, Moubarak RS. CD44 ligation induces caspase-independent cell death via a novel calpain/AIF pathway in human erythroleukemia cells. Oncogene. 2006, 25:5741-51.
35. Song G, Liao X, Zhou L. HI44a, an anti-CD44 monoclonal antibody, induces differentiation and apoptosis of human acute myeloid leukemia cells. Leuk Res. 2004, 28:1089-96.
36. Wu L, Kincade PW, Shortman K. The CD44 expressed on the earliest intrathymic precursor population functions as a thymus homing molecule but does not bind to hyaluronate. Immunol Lett. 1993, 38:69-75.
37. Rajasagi M, Vitacolonna M, Benjak B. CD44 promotes progenitor homing into the thymus and T cell maturation. J Leukoc Biol. 2009, 85:251-61.
38. Scimone ML, Aifantis I, Apostolou I. A multistep adhesion cascade for lymphoid progenitor cell homing to the thymus. Proc Natl Acad Sci USA. 2006, 103:7006-11.
39. Koch N, Hämmerling GJ, Tada N. Cross-blocking studies with monoclonal antibodies against I-A molecules of haplotypes b, d and k. Eur J Immunol. 1982, 12:909-14.
40. Hession C, Moy P, Tizard R. Cloning of murine and rat vascular cell adhesion molecule-1. Biochem Biophys Res Commun. 1992, 183:163-9.
41. Ogasawara J, Watanabe-Fukunaga R, Adachi M. Lethal effect of the anti-Fas antibody in mice. Nature. 1993, 364:806-9.
42. Taylor SJ, Resnick RJ, Shalloway D. Nonradioactive determination of Ras-GTP levels using activated ras interaction assay. Methods Enzymol. 2001, 333:333-42.
43. Cossarizza A, Salviolit S. Analysis of mitochondria during cell death. Methods Cell Biol. 2001, 63:467-86.
44. Hériché JK, Lebrin F, Rabilloud T. Regulation of protein phosphatase 2A by direct interaction with casein kinase 2 alpha. Science. 1997, 276:952-5.
45. Eichhorn PJ, Creyghton MP, Bernards R. Protein phosphatase 2A regulatory subunits and cancer. Biochim Biophys Acta. 2009, 1795:1-15.
46. Schwärzler C, Oliferenko S, Günthert U. Variant isoforms of CD44 are required in early thymocyte development. Eur J Immunol. 2001, 31:2997-3005.
47. Avin E, Haimovich J, Hollander N. Anti-idiotype x anti-CD44 bispecific antibodies inhibit invasion of lymphoid organs by B cell lymphoma. J Immunol. 2004, 173:4736-43.
48. Alpdogan SO, Lu SX, Patel N. Rapidly proliferating CD44hi peripheral T cells undergo apoptosis and delay posttransplantation T-cell reconstitution after allogeneic bone marrow transplantation. Blood. 2008, 112:4755-64.
49. Ludowyke RI, Holst J, Mudge LM. Transient translocation and activation of protein phosphatase 2A during mast cell secretion. J Biol Chem. 2000, 275:6144-52.
50. Van Hoof C, Goris J. Phosphatases in apoptosis: to be or not to be, PP2A is in the heart of the question. Biochim Biophys Acta. 2003, 1640:97-104.
51. Ruvolo PP, Clark W, Mumby M. A functional role for the B56 alpha-subunit of protein phosphatase 2A in ceramide-mediated regulation of Bcl2 phosphorylation status and function. J Biol Chem. 2002, 277:22847-52.
52. Chiang CW, Kanies C, Kim KW. Protein phosphatase 2A dephosphorylation of phosphoserine 112 plays the gatekeeper role for BAD-mediated apoptosis. Mol Cell Biol. 2003, 23:6350-62.
53. Zolnierowicz S. Type 2A protein phosphatase, the complex regulator of numerous signaling pathways. Biochem Pharmacol. 2000, 60:1225-35.
54. Pérez M, Avila J. The expression of casein kinase 2alpha' and phosphatase 2A activity. Biochim Biophys Acta. 1999, 1449:150-6.
55. Lebrin F, Bianchini L, Rabilloud T. CK2alpha-protein phosphatase 2A molecular complex: possible interaction with the MAP kinase pathway. Mol Cell Biochem. 1999, 191:207-12.
56. Ramos JW. The regulation of extracellular signal-regulated kinase (ERK) in mammalian cells. Int J Biochem Cell Biol. 2008, 40:2707-19.
57. Letourneux C, Rocher G, Porteu F. B56-containing PP2A dephosphorylate ERK and their activity is controlled by the early gene IEX-1 and ERK. EMBO J. 2006, 25:727-38.
58. Ewings KE, Wiggins CM, Cook SJ. Bim and the pro-survival Bcl-2 proteins: opposites attract, ERK repels. Cell Cycle. 2007, 6:2236-40.
59. Deng X, Ruvolo P, Carr B. Survival function of ERK1/2 as IL-3-activated, staurosporine-resistant Bcl2 kinases. Proc Natl Acad Sci USA. 2000, 97:1578-83.
60. Alvarado-Kristensson M, Andersson T. Protein phosphatase 2A regulates apoptosis in neutrophils by dephosphorylating both p38 MAPK and its substrate caspase 3. J Biol Chem. 2005, 280:6238-44.
61. Dessauge F, Cayla X, Albar JP. Identification of PP1alpha as a caspase-9 regulator in IL-2 deprivation-induced apoptosis. J Immunol. 2006, 177:2441-51.